Guidelines for reporting health research: The EQUATOR network's survey of guideline authors

PLoS Medicine

Volumn 5, Issue 6, 2008, Pages 0869-0874

  Simera, Iveta ^a   Altman, Douglas G ^a   Moher, David ^b   Schulz, Kenneth F ^c,d   Hoey, John ^e  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^c FAMILY HEALTH INTERNATIONAL   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; MEDICAL LITERATURE; MEDICAL RESEARCH; PRACTICE GUIDELINE; PUBLICATION; QUESTIONNAIRE; INFORMATION PROCESSING; INFORMATION RETRIEVAL; INTERNET; METHODOLOGY; PUBLISHING; RESEARCH; STANDARD;

DATA COLLECTION; GUIDELINES AS TOPIC; INFORMATION STORAGE AND RETRIEVAL; INTERNET; PUBLISHING; QUESTIONNAIRES; RESEARCH; RESEARCH DESIGN;

EID: 46749106006     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0050139     Document Type: Article

References (37)

1. Chan AW, Altman DG (2005) Epidemiology and reporting of randomised trials published in PubMed journals. Lancet 365: 1159-1182.
2. Gibson CA, Kirk EP, LeCheminant JD, Bailey BW Jr., Huang G, et al. (2005) Reporting quality of randomized trials in the diet and exercise literature for weight loss. BMC Med Pes Methodol 5: 9.
3. Hayden JA. Cote P, Bombardier C (2006) Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 144: 427-437.
4. Latronico N, Botteri M, Minelli C, Zanotti C, Berlolini G, el al. (2002) Quality of reporting of randomised controlled trials in the intensive care literature. A systematic analysis of papers published in Intensive Care Medicine over 26 years. Intensive Care Med 28: 1316-1323.
5. Lee CW, Chi KN (2000) The standard of reporting of health-related quality of life in clinical cancer trials, J Clin Epidemiol 53: 451-458.
6. Long CR, Nick TG, Kao C (2004) Original research published in the chiropractic literature: Evaluation of the research report. J Manipulative Physiol Ther 27: 223-228.
7. Mallett S, Deeks J, Halligan S, Hopewell S, Cornelius V, et al. (2006) Systematic reviews of diagnostic tests in cancer: Review of methods and reporting. BMJ 333: 413.
8. Mills E, Loke YK, VVu P, Monlori VM, Perri D, et al. (2004) Determining the reporting quality of RCTs in clinical pharmacology. Br J Clin Pharmacol 58: 61-65.
9. Pocock SJ, Collier TJ, Dandreo KJ, de Stavola BL, Goldman MB, el al. (2004) Issues in the reporting of epidemiological studies: A survey of recent practice. BMJ 329: 883.
10. Riley RD, Abrams KR, Sutton AJ, Lambert PC Jones DR, el al. (2003) Reporting of prognostic markers: Current problems and development of guidelines for evidence-based practice in the future. Br J Cancer 88: 1191-1198.
11. Smidt N, Rutjes AW, van der Windt DA, Ostelo RW, ReitsmaJB, et al. (2005) Quality of reporting of diagnostic accuracy studies. Radiology 235: 347-353.
12. Thakur A, Wang EC, Chiu TT, Chen W, Ko CY, et al. (2001) Methodology standards associated with quality reporting in clinical studies in pediatric surgery journals. J Pediatr Surg 36: 1160-1164.
13. Moher D, Schulz KF, Altman DG (200 1) The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357: 1191-1194.
14. Moher D, Cook DJ, Eastwood S, Olkin L Retime D, etal. (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354: 1896-1900.
15. Bossuyt PM, Reilsma JB, Brans DE, Galsonis CA, Glasziou PP, el al. (2003) Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 49: 1-6.
16. STROBE Initiative (2007) STROBE statement: Strengthening the reporting of observational studies in epidemiology. Available: http://www,strobe-slatement. org/.. Accessed 21 May 2008.
17. McShane LM, Airman DG, Sauerbrei W, Taube SE, Gion M, etai. (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93: 387-391.
18. Flint AC, Moher D, Morrison A, Schulz K, Aitman DG, et al. (2006) Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review. Med J Aust 185: 263-267.
19. Smidt N, Rutjes AWS, van der Windt DAWM, Ostelo RWJG, Bossuyt PM, et al. (2006) The quality of diagnostic accuracy studies since the STARD statement: Has it improved? Neurology 67: 792-797.
20. Booth A (2006) "Brimful of STARLITE": Toward standards for reporting literature searches. J Med Eibr Assoc 9-1: 421-429, e205.
21. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001) Minimum information about a mirroarray experiment (MIAME) toward standards for microarray data. Nat Genet 29: 365-371.
22. HUPO Proieomics Standards Initiative (2008) The minimum information about a proteomics experiment (MIAPE): Reporting guidelines for proteomics, Available: http://www.psidev.info/index.php?q-node/91.. Accessed 21 May 2008.
23. Campbell MK, Eibourne DR, Altman DG (2004) CONSORT statement: Extension to cluster randomised trials. BMJ 328: 702-708.
24. Davidson KW, Goldstein M, Kaplan KM, Kaufmann PG, Knatterud GL, et al. (2003) Evidence-based behavioral medicine: What is it and how do we achieve it? Ann Behav Med 26: 161-171.
25. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, et al. (2006) Reporting randomized, controlled trials of herbal interventions: An elaborated CONSORT statement. Ann Intern Med 144: 364-367.
26. loannidis JPA, Evans SJW, Gotzsche PC, O'Neill RT, All man DG, et al. (2004) Better reporting of harms in randomized trials: An extension of the CONSORT statement. Ann Intern Med 141: 781-788.
27. MacPherson H, While A, Cummings M, Jobst K, Rose X, el al. (2002) Standards for reporting interventions in controlled trials of acupuncture: The STRICTA recommendations. STandards for Reporting Interventions in Controlled Trails of Acupuncture. Acupunct Med 20: 22-25.
28. Piaggio G, Flbourne DR, Aitman DG, Pocock SJ, Evans SJW, et al. (2006) Reporting of nonmferioriry and equivalence randomized trials: An extension of the CONSORT statement. JAMA 295: 1152-1160.
29. Chang SM, Reynolds SL, Butowski N, Lamborn KR. BucknorJC, et al, (2005) GNOSIS: Guidelines for neuro-oucology: Standards for investigational studies-reporting of phase 1 and phase 2 clinical trials. Neuro Oncol 7: 425-434.
30. Spiegelhaller DJ, Myles JP, Jones DR, Abrams KR (2000) Rayesian methods in health technology assessment: A review. Health Technol Assess 4: 1-130.
31. Aronson JK (2003) Anecdotes as evidence: We need guidelines for reporting anecdotes of suspected adverse drug reactions. BMJ 326: 1346.
32. David off F, Batalden P (2005) Toward stronger evidence on quality improvement. Draft publication guidelines: the beginning of a consensus project. Qual Saf Health Care 14: 319-325.
33. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J et al. (2003) Standardized reporting of clinical practice guidelines: A proposal from the Conference on Guideline Standardization. Ann Intern Med 139: 493-498.
34. Sung L, Hayden J, Greenberg ML, Koren G, Feldman BM, el al. (2005) Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. J Clin Epidemiol 58: 261-268.
35. Wager E, Field EA, Grossman L (2003) Good publication practice for pharmaceutical companies. Curr Med Res Opin 19: 149-154.
36. Stone SP, Cooper BS, Kibbler CC, Gookson BD, Roberts JA, et al. (200?) The ORION statement: Guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet infect Dis 7: 282-288.
37. Aitman DG, for the CONSORT Group (2005) Endorsement of the CONSORT statement by high impact medical journals: Survey of instructions for authors. BMJ -530: 1056-1057.